Pulmonx Corporation PE Ratio 2019-2024 | LUNG
Current and historical p/e ratio for Pulmonx Corporation (LUNG) from 2019 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pulmonx Corporation PE ratio as of February 21, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pulmonx Corporation PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-21 | 8.96 | 0.00 | |
| 2024-09-30 | 8.29 | $-1.47 | 0.00 |
| 2024-06-30 | 6.34 | $-1.50 | 0.00 |
| 2024-03-31 | 9.27 | $-1.54 | 0.00 |
| 2023-12-31 | 12.75 | $-1.60 | 0.00 |
| 2023-09-30 | 10.33 | $-1.62 | 0.00 |
| 2023-06-30 | 13.11 | $-1.61 | 0.00 |
| 2023-03-31 | 11.18 | $-1.58 | 0.00 |
| 2022-12-31 | 8.43 | $-1.59 | 0.00 |
| 2022-09-30 | 16.66 | $-1.56 | 0.00 |
| 2022-06-30 | 14.72 | $-1.46 | 0.00 |
| 2022-03-31 | 24.81 | $-1.40 | 0.00 |
| 2021-12-31 | 32.07 | $-1.31 | 0.00 |
| 2021-09-30 | 35.98 | $-1.23 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||